Relmada Therapeutics Inc (RLMD)
3.35
-0.14
(-4.01%)
USD |
NASDAQ |
May 17, 16:00
3.35
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Cash from Investing (Quarterly): 10.06M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.06M |
| December 31, 2023 | 7.741M |
| September 30, 2023 | 3.860M |
| June 30, 2023 | -1.152M |
| March 31, 2023 | 40.00M |
| December 31, 2022 | -1.655M |
| September 30, 2022 | 31.56M |
| June 30, 2022 | -0.1405M |
| March 31, 2022 | -10.03M |
| December 31, 2021 | -91.18M |
| September 30, 2021 | 27.51M |
| June 30, 2021 | -5.912M |
| March 31, 2021 | 15.47M |
| December 31, 2020 | 0.9353M |
| September 30, 2020 | 4.588M |
| June 30, 2020 | -16.34M |
| March 31, 2020 | -23.63M |
| September 30, 2019 | |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | -0.0098M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0026M |
| June 30, 2017 | -0.0022M |
| March 31, 2017 | -0.0202M |
| December 31, 2016 | -0.0024M |
| September 30, 2016 | -0.0248M |
| June 30, 2016 | -0.023M |
| March 31, 2016 | -0.0631M |
| December 31, 2015 | -0.4748M |
| September 30, 2015 | -0.0013M |
| June 30, 2015 | -0.0039M |
| March 31, 2015 | -0.0023M |
| December 31, 2014 | -0.0065M |
| September 30, 2014 | -0.0107M |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | -0.0018M |
| February 28, 2013 | 0.00 |
| November 30, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-91.18M
Minimum
Dec 2021
40.00M
Maximum
Mar 2023
-0.4622M
Average
0.4676M
Median
Cash from Investing (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.00 |
| Lifecore Biomedical Inc | -7.50M |
| Harrow Inc | -0.11M |
| Corvus Pharmaceuticals Inc | -0.007M |
| Aquestive Therapeutics Inc | -0.029M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.04M |
| Cash from Financing (Quarterly) | 0.2217M |
| Free Cash Flow | -48.19M |
| Free Cash Flow Per Share (Quarterly) | -0.4327 |
| Free Cash Flow Yield | -47.92% |